| Autor: |
Zhijing Na, Jiahui Song, Yaxin Meng, Di Feng, Jingzan Wei, Hongyu Jiang, Hongyue Yang, Yuanyuan Peng, Dongkai Cheng, Yuanyuan Fang, Da Li |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Reproductive biomedicine online. 45(3) |
| ISSN: |
1472-6491 |
| Popis: |
Is there an association between fructose and dislipidaemia in polycystic ovary syndrome (PCOS)?Serum fructose levels were measured in 250 women with PCOS (113 with dislipidaemia, 137 with normolipidaemia) and 460 controls (70 with dislipidaemia, 390 with normolipidaemia). Logistic regression was used to model the relationship between serum fructose levels and dyslipidaemia. Receiver operating characteristic curve analysis was used to assess the ability of serum fructose levels to predict dislipidaemia in women with PCOS, and PCOS in women with dislipidaemia.Patients with PCOS and dislipidaemia had higher serum fructose levels. Triglycerides, total cholesterol and low-density lipoprotein cholesterol increased with increasing serum fructose quartiles in patients with PCOS, whereas high-density lipoprotein cholesterol decreased (all P0.001). Among the lipid metabolism-related indicators, triglycerides were most associated with fructose (R = 0.626, P0.001). Serum fructose at a cut-off value of 9.79 pmol/µl had a sensitivity of 83.2% and specificity of 66.4% for predicting dislipidaemia in women with PCOS. Lower serum fructose levels were strongly associated with a decreased risk of dislipidaemia in women with PCOS (P0.001; OR 0.067; 95% CI 0.027 to 0.170). Moreover, high fructose levels are predictive of PCOS in women with dislipidaemia, with a better diagnostic performance than the androgens typically used as markers.Serum fructose levels are significantly correlated with dislipidaemia in women with PCOS, highlighting the importance of investigating the role of fructose in lipid metabolism of PCOS. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect